Abstract:Background: The Von Hippel-Lindau (VHL) gene is a tumor-suppressor gene. Recent studies have shown that low expression of VHL has a close relationship with tumor formation, progression, and prognosis. Hypoxia-inducible factor (HIF)-1 alpha is a transcription factor, which exists universally in mammals including humans under states of hypoxia. Some studies have also shown that expression of HIF-1 alpha closely correlates with tumor progression, angiogenesis, metastasis, and invasion. This molecule is also an important cytokine, which may be used to evaluate the prognosis of some malignant tumors. In this study, we studied the expression of VHL and HIF-1 alpha and evaluated their clinicopathologic significance and relationship in benign and malignant lesions of the gallbladder.Methods: EnVision immunohistochemistry was used for detecting the expression level of VHL and HIF-1 alpha in routinely paraffin-embedded sections from specimens of gallbladder adenocarcinoma (n = 108), peritumoral tissues (n = 46), adenomatous polyps (n = 15), and chronic cholecystitis (n = 35).Results: The frequency of positive VHL expression was significantly lower in adenocarcinoma of gallbladder (48.1%) than that in peritumoral tissues (80.4%), adenomatous polyps (80.0%), and chronic cholecystitis (88.6%) (P < 0.05 or P < 0.01). In contrast, the positive HIF-1 alpha expression was significantly higher in adenocarcinoma (53.7%) than that in peritumoral tissues (34.8%), adenomatous polyps (26.7%), and chronic cholecystitis (14.3%) (P < 0.05 or P < 0.01). The benign lesions with positive VHL and/or negative HIF-1 alpha expression showed atypical hyperplasia in gallbladder epithelium. The positive expression of VHL and negative expression of HIF-1 alpha were significantly associated with differentiation, tumor mass, lymph node metastasis, and invasion of adenocarcinoma (P < 0.05 or P < 0.01). The highly inconsistent expression of VHL and HIF-1 alpha in gallbladder adenocarcinoma was found P < 0.01). Univariate Kaplan-Meier analysis showed that elevated expression of VHL (P = 0.023) or lowered expression of HIF-1 alpha (P = 0.020) was closely associated with decreased overall survival. Multivariate Cox regression analysis showed that positive expression of VHL (P = 0.013) and/or negative expression of HIF-1 alpha (P = 0.005) was an independent poor-prognostic predictor in gallbladder adenocarcinoma.Conclusions: The lowered expression of HIF-1 alpha and elevated expression of VHL in gallbladder adenocarcinoma are important markers for the progression, clinical biological behavior, and prognosis. Measurement of VHL and HIF-1 alpha expression could be a tool for early detection of gallbladder cancer in benign lesions and in population screening. The highly inconsistent expression of VHL and HIF-1 alpha in gallbladder may require further study to see whether they are intrinsically related.

Association of P53, P16, and Vascular Endothelial Growth Factor Protein Expressions with the Prognosis and Metastasis of Gallbladder Cancer

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

Analysis of P53 and Vascular Endothelial Growth Factor Expression in Human Gallbladder Carcinoma for the Determination of Tumor Vascularity

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Analysis of P53 and Vascular Endothelial Growth Factor and Its Receptor Flk-1 Expression in Human Gallbladder Carcinoma for Determination of Tumor Vascularity

Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma

Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Carcinoma of Ampulla of Vater.

Prognostic Implications of Estrogen Receptor 1 and Vascular Endothelial Growth Factor A Expression in Primary Gallbladder Carcinoma.

Association of Cyclin D1, P16 and Retinoblastoma Protein Expressions with Prognosis and Metastasis of Gallbladder Carcinoma

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis

Correlation of P-glycoprotein Expression with Poor Vascularization in Human Gallbladder Carcinomas.

Correlation between p53 Mutation and Carcinoangiogenesis in Gallbladder Cancer

Expression of P62 in Gallbladder Carcinoma Tissues and Its Correlation with Angiogenesis

Correlation of P53 and Vascular Endothelial Growth Factor Expression to Angiogen Esis in Gastric Carcinoma and Its Clinical Significance

Relationship between expression of VEGF, Flt1, bFGF and P53 and outcome in patients with gastric carcinoma

Expression and Its Significance of VEGF in Gallbladder Carcinomas

The Clinical Significance of Tumor Angiogenesis and Invasiveness-Related Gene Expressions in Gastric Cancer

Expression of P53, EGFR, HER-2, VEGF in Gastric Carcinoma and Its Relation with the Prognosis of Gastric Carcinoma Patients

Expression of P16 and VEGF in Gastric Carcinoma and Its Clinical Significance

Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder